Hypothesis\n\nIt's becoming clear that the functional age of the gut microbiome—measured by a decline in tryptophan‑derived metabolites such as indole‑3‑propionic acid (IPA)—precedes and predicts systemic inflammaging and neurocognitive decline more accurately than host epigenetic clocks.\n\n## Mechanistic Basis\n\n1. Microbial metabolite loss – Age‑related shifts reduce Clostridium spp. that produce IPA, a ligand for the aryl hydrocarbon receptor (AhR) in intestinal epithelial cells.\n2. Barrier weakening – Reduced AhR signaling lowers expression of tight‑junction proteins and mucin, increasing permeability and allowing LPS translocation Age-related dysbiosis drives systemic inflammation and neuroinflammation through increased intestinal permeability.\n3. Senescent cell amplification – LPS‑triggered TLR4 activation accelerates enterocyte senescence, which in turn secretes SASP factors that further suppress beneficial microbes, creating a feed‑forward loop Reciprocal senescence-dysbiosis loop exacerbates barrier dysfunction and inflammation.\n4. Neuroimmune priming – Circulating LPS and SASP cytokines (IL‑1β, TNF‑α) cross the compromised barrier, priming microglia via TLR4 and NF‑κB, lowering the threshold for subsequent activation by amyloid‑β or tau Increased intestinal permeability allows microbial LPS to activate microglia.\n5. Metabolite‑mediated microglial modulation – Simultaneously, increased microbial production of indoxyl sulfate generates oxidative stress in microglia, shifting them toward a pro‑inflammatory phenotype.\n\nThus, the microbiome’s metabolic ‘age’ directly regulates both gut barrier integrity and microglial readiness, positioning it as an upstream driver of inflammaging‑linked neurodegeneration.\n\n## Testable Predictions\n\n- Longitudinal declines in fecal IPA will predict rises in serum zonulin and LPS‑binding protein within 6‑12 months, preceding measurable increases in plasma IL‑6 and CRP.\n- Individuals showing early IPA loss will exhibit higher PET‑detected microglial activation (TSPO signal) and faster decline in episodic memory scores over two years, independent of baseline epigenetic age.\n- Supplementation with an IPA‑producing prebiotic (e.g., pectin‑rich diet) will restore fecal IPA, reduce intestinal permeability, lower senescence markers in colonic biopsies, and attenuate microglial activation in aged mice.\n\n## Experimental Approach\n\n- Human cohort: Recruit 200 adults aged 60‑80, collect quarterly stool for metabolomics (targeted IPA, indoxyl sulfate), serum for zonulin, LPS, cytokines, and annual cognitive testing; sub‑set undergo colonic biopsies for p16INK4a and SA‑β‑gal staining.\n- Mouse validation: Treat aged mice with broad‑spectrum antibiotics to eradicate IPA producers, then colonize with either IPA‑producing Clostridium sporogenes or a deficient mutant; assess barrier function, senescence, LPS levels, TSPO PET, and behavior.\n- Intervention trial: Randomized, double‑blind study giving IPA‑enriched prebiotic vs placebo for 6 months; primary outcomes: change in fecal IPA, serum zonulin, and cognitive composite score.\n\n## Potential Impact\n\nIf validated, the microbiome’s metabolic age could become a actionable biomarker, guiding personalized prebiotic or precision‑edited microbiota interventions to break the senescence‑dysbiosis loop before irreversible neuroinflammation sets in.\n\nGut-brain communication relies on vagus nerve, immune system, endocrine signals, and SCFAs\nSenolytics reduce enterocyte senescence and modulate microbiota specifically in aged mice\nFMT from long-living humans reduces senescence markers and increases beneficial bacteria